We have, however, demonstrated a population of suppressor T cells (Ts cells) that is activated by I-A antigens of the haplotype encountered neonatally and that nonspecifically suppresses primary PFC responses in culture. This report describes some properties of these Ts cells and the genetic restrictions governing their activation and function, and discusses their possible significance. Antigens. GAT (~45,000 mol wt; Miles Laboratories Inc., Elkhart, Ind.) was prepared as previously described for use as antigen in culture (15) , preparing GAT-M~ (6), coupling to sheep erythrocytes (SRBC) for use as indicator cells in the hemolytic PFC assay (15) , and for in vivo immunization (15) . Trinitrophenol (TNP)-derivitized sheep and horse erythrocytes (TNP-SRBC and TNP-HRBC) were prepared by the techniques of Rittenberg and Pratt (16) and used as antigen in culture or as indicator cells in the PFC assay. Keyhole limpet hemocyanin (KLH) and Brucella abortus (BA) were derivatized with TNP as described by Zitron et al. (17) .
Materials and Methods

Mice
Immunizations. Neonatal B10 or BALB/c mice received 20 X 106 syngeneic or (B10.D2 X BI0)F1 spleen cells in phosphate-buffered Ringer's solution, pH 7.6, via the orbital branch of the anterior facial vein within 18 h of birth, as described by Billingham et al. (11, 12) . Mice were analyzed for immune reactivity at 6-20 wk of age. Adult mice were immunized by intraperitoneal injections of 10 #g GAT in a mixture of magnesium-aluminum hydroxide (Maalox; W. H. Roher, Inc., Ft. Washington, Pa.) and pertussis vaccine (Eli Lilly, Indianapolis, 6 6 Ind.; 15) or 4 X 10 of the appropriate GAT-M~ (bearing ~25 ng GAT/10 cells; 6).
Preparation of Cell Populations. T cells were separated from single cell suspensions of lymph node or spleen by passage over nylon wool columns (18) . Peritoneal exudate cells (PEC) obtained by flushing the peritoneal cavity of the mice with Hanks' balanced salt solution containing 10 IU/ml heparin were the source of M~. Spleen cells were treated with anti-Thy-1.2 serum and complement (C) and used as T celt-depleted spleen cells (t0). Spleen cells were irradiated as indicated using a Gamma-Cell 40 la7Cs source (Atomic Energy of Canada, Ltd., Ottawa, Canada). (19) . GAT-MO were prepared using appropriate PEC as previously described (6) and had -2-4 ng CAT/105 cells. TNP-KLH-M~ were prepared by incubating 2 × 10 e PEC with 100 #g/ml TNP-KLH in serum-free medium at 37°C for 60 min. Cells were washed, resuspended in medium, and added to culture. IgG GAT-specific, IgM and IgG anti-SRBC, or IgM and IgG TNP-specific PFC responses were assayed using the slide modification of the Jerne hemolytic plaque assay (19 (Table II) . Spleen cells from normal or control B10 mice developed significant responses to soluble GAT and to GAT-Mq~ from syngeneic B10 and allogeneic AKR and B10.D2 mice. Spleen cells from neonatally treated B10 mice responded to soluble GAT and to GAT presented on syngeneic B 10 and unrelated allogeneic AKR-Mq~, but failed to respond to BI0.D2 or (B10.D2 × B10)F1 GAT-M~b. Neonatally treated mice also failed to respond to SRBC in the presence of B 10.D2 M~ but responded at control levels in the presence of allogeneic AKR M~. An identical pattern of responsiveness was observed in BALB/c spleen cells from mice treated as neonates with (B10.D2 × B10)F1 spleen cells; these spleen cells failed to respond to B 10 GAT-Mq~ but responded to BALB/c and AKR GAT-Mth and soluble GAT (data not shown). In all experiments, responses to SRBC in the absence of added syngeneic or allogeneic Mth were comparable.
Results
Immune Responses by
Demonstration of Haplotype-specific Ts Cells. The role of active suppression as the basis for the specific failure to respond to GAT-M~ of the H-2 haplotype that the mice were exposed to as neonates was investigated. Spleen cells or T cells from control or neonatally treated B10 mice were added to normal B10 spleen cells in cultures stimulated with GAT-Mth of various H-2 haplotypes (Table III) The activity of these suppressor cells was completely abrogated by treatment with anti-Thy-l.2 plus C and as little as 350 rad gamma irradiation (Table III) . More complete characterization of these Ts cells will be the subject of a future communication. The addition of normal T cells to spleen cells from neonatally treated mice, depleted ofT cells, restored the capacity to develop PFC responses to allogeneic GATMq~ of the haplotype encountered as neonates. These results suggested that the B cell pool was intact and unaffected by the neonatal treatment that had induced a population of radiosensitive, haplotype-specific Ts cells. The kinetics of suppression of primary PFC responses by haplotype-specific Ts cells was investigated under conditions in which the Ts cells were activated by adding the relevant Mq~ at various times after the initiation of cultures containing normal B10 spleen cells and B10 spleen cells from neonatally treated mice (Table IV) . Complete suppression of day 5 responses was observed only when the allogeneic B10.D2 Mq~ were added within 24 h of culture initiation. Suppression was significant but incomplete when the Ts cells were activated at 36 h and was more variable, ranging from 0 to ~50%, when Ts cells were activated at 48 h. Higher numbers of Mq~ added at or after 48 h were unable to activate Ts cells to suppress day 5 responses (data not shown). Ts cells, preactivated with the appropriate Mq~ for 48 h, failed to suppress PFC responses completely when added to culture 48 h after initiation, but when added at culture initiation or 24 h after culture initiation, the Ts cells blocked initiation of the PFC responses.
Parameters of Suppression by
The ability of these haplotype-specific Ts cells to suppress secondary PFC responses to GAT was examined. Spleen cells from mice primed with syngeneic or allogeneic GAT-Mq~ developed secondary responses to GAT only when stimulated with GATMq~ syngeneic to the Mq~ used for priming in vivo (6, 20) . B10 mice were immunized with B10, B10.D2, or (B10.D2 × B10)F1 GAT-Mq~; spleen cells from these mice developed secondary PFC responses only to the GAT-Mq~ syngeneic to those used for immunization (Table V) . Ts cells from neonatally treated B 10 mice, which suppressed primary PFC responses when exposed to the appropriate allogeneic GAT-Mq~, failed to suppress secondary PFC responses to the same GAT-Mq~. Thus, although these Ts cells can suppress PFC responses to a variety of antigens, only primary responses were suppressed. Moreover, neonatally treated mice cannot be primed using GAT-Mth against which the Ts cells are directed.
Finally, these haplotype-specific Ts cells were unable to suppress either CTL or MLR to the B10.D2 alloantigens (Table VI) Genetic Constraints Governing Activity of Haplotype-specific Ts Cells. The subregion(s) of the H-2 complex responsible for the activation and restriction of activity of these Ts cells was determined using congenic and recombinant strains of mice in mapping studies. First, using Mq~ from mice that shared regions of the H-2 complex with the allogeneic parent of the Fx cells administered to the neonates, the genetic requirements for activation of the Ts cells were determined (Table VII) . B10.D2, C3H.OL, and B10.GD, but not BI0.
LG, GAT-Mq~ activated B10 Ts cells specific for the H-2 d haplotype resulting in suppression of responses by normal B10 spleen cells. Thus, syngenicity at the I-A subregion of the H-2 complex was necessary and sufficient for activation of Ts cells. Second, the genetic restrictions on haplotype-specific Ts cell activity were determined using Ts cells activated by the appropriate GAT-M~b and normal responder spleen cells that shared various regions of the H-2 complex (Table  VIII) . This analysis was potentially complicated because Ts cells and responding cells differ at some regions of the H-2 complex. In experiment 1, responses by B10, B10.A(3R), and B10.A(5R) spleen cells were suppressed by B10 Ts cells activated by the B 10.D2 Mq~, placing the restriction in the K, I-A, and I-B subregions and definitely eliminating syngenicity at the I-J subregion as a requirement for expression of suppressive activity. The data in experiment 2 demonstrated that syngenicity at the I-A subregion of H-2 was necessary and sufficient for the Ts cells to express activity. Discussion Mice injected within 18 h of birth when semiallogeneic F1 spleen cells, using a protocol for induction of alloantigen-specific tolerance described by Billingham et al. (11, 12) , were not unresponsive to antigens of the allogeneic haplotype in the F1 donor. These mice rejected skin grafts of the allogeneic haplotype with normal kinetics; spleen cells from these treated mice developed reduced but significant MLR and CTL responses when stimulated with the appropriate alloantigens. Spleen cells from these mice, however, did not develop primary in vitro PFC responses when Mq~ from the allogeneic haplotype encountered as neonates were present in the culture. This unresponsiveness was due to a population of radiosensitive haplotype-specific Ts cells that were activated by the alloantigens encountered as neonates. These Ts cells nonspecifically suppressed in vitro primary, but not secondary, PFC responses to a variety of antigens and failed to suppress MLR and CTL responses. These Ts cells were activated by cells that shared antigens encoded by the I-A subregion of the H-2 complex with the allogeneic parent in the F1 cells encountered neonatally. Moreover, syngenicity at the I-A subregion between the Ts cell and its target responding spleen cells was necessary and sufficient to mediate suppression.
TA~X.E VIII
Genetic Restrictions on Haplotype-specific Ts Cell Activity
Active T cell-mediated suppression has been demonstrated to regulate immune responses in a variety of experimental systems. One example analogous to the findings reported here is the MLR suppressor system described by Rich and Rich (21, 22) , in which a genetically restricted population of Ts cells capable of inhibiting a primary MLR was demonstrated. These Ts cells were stimulated by immunizing parental strains of mice with appropriate F1 spleen cells; 4 d later, Ts cells were tested for activity in a primary MLR. We were unable to demonstrate suppression of the MLR under any of the conditions of our assays, unlike the suppression evident in the MLR suppressor system, although the mechanism of stimulation of the two types of Ts cells were similar. Another important difference in the two systems is the genetic constraints on the Ts cells. The MLR Ts cell required syngenicity at the I-E/C subregion of the H-2 complex with its target cell (23) , whereas the haplotype-specific Ts cell described here required syngenicity at the I-A subregion, both at the level of activation and at the effector stage. Further, the MLR Ts cell had a relatively short life span; activity was maximal 4 d after induction but was not demonstrable by 7 d. In contrast, although the presence of haplotype-specific Ts cells has not been investigated at less than 8 wk after injection of F1 spleen cells, Ts cells have been demonstrated as late as 5 mo after treatment, suggesting that these Ts cells were a relatively long-lived population.
These two Ts cell systems, although independent phenomena, shared some characteristics; both are examples of Ts cells not restricted by the I-J subregion of the H-2 complex, in contrast to antigen specific Ts cells (24, 25) . These Ts cells, however, are stimulated and interact with target cells in a genetically restricted manner controlled by the I-A subregions. It should be noted that the absence of I-J determinants on the Ts cell has not been demonstrated, only that syngenicity at the I-J subregion is irrelevant with respect to function. These two cell systems also demonstrate a phenomenon observed with some antigen-specific Ts cells, a certain degree of nonspecificity at the effector stage after activation (26, 27) . The haplotype-specific Ts cell after activation by the appropriate stimulus inhibits the primary antibody responses by any spleen cells syngeneic at the I-A subregion, whereas the MLR Ts cell inhibits responses by any responder cell syngeneic at the I-E/C subregions (23).
Important considerations concerning the possible mechanism(s) of action of these Ts cells are the failure to inhibit T cell responses and secondary antibody responses, and required presence of Ts cells during the first 36 h of culture to achieve significant suppression of the primary response; similar constraints have previously been reported for the GAT system (28) . The kinetics of suppression suggest that the regulatory step occurs early in the generation of the primary antibody response; thus appropriate target cells may not be required or susceptible in responses by primed spleen cells or virgin spleen cells 48 h or more after culture initiation. This implies that the target cell(s), possibly an amplifier T cell, is necessary for the primary, but not the secondary, response and is not the same amplifier T cell involved in the MLR; the precedent for such a difference has been previously suggested (29) . Alternatively, the unprimed B cell may be the target cell; further studies to determine the target cells of these Ts cells are in progress.
It is important to consider some of the problems inherent in the tolerance system used in this study that may bear on the findings. The inability to induce tolerance by classical criteria is potentially disturbing, but appears to be a function of both the B10 genetic background of the mice used and the relative difficulty of inducing tolerance to antigens of the left half of the H-2 complex (13, 15, 30, 31) ; higher doses of F1 cells administered to the neonates also failed to induce tolerance. Attempts to induce tolerance in neonatal BALB/c mice using (BALB/c × A)F1 (CAF 0 cells, thus eliminating the problem of the B 10 background and reducing the antigenic differences at H-2, have resulted in a higher incidence of tolerance by MLR and CTL responses and skin graft rejection but, interestingly, the phenomenon of haplotype-specific Ts cells as reported here were unchanged (C. Sorensen and C. W. Pierce, unpublished data). More difficult observations to explain are the "partial tolerance" induced to the appropriate alloantigens in MLR and CTL responses, but the complete unresponsiveness observed in antibody responses in the presence of the appropriate alloantigens. This is compounded by the observations that the Ts cells responsible for lack of antibody responses are unable to suppress MLR and CTL responses. This paradox is under investigation.
A final point concerns the potential mechanism of action of these Ts cells. Most Ts cell systems described to date involve a soluble mediator; this system is not an exception. The demonstration and characterization of a soluble factor mediating haplotype-specific suppression is the subject of the accompanying report (32) . Summary C57BL/10 mice were injected with semiallogeneic (B10.D2 X C57BL/10)F1 spleen cells via the anterior facial vein within 24 h of birth to induce tolerance to B10.D2 (H-2 d) alloantigens. Spleen cells from these mice as adults developed reduced, but significant, mixed lymphocyte and cytotoxic lymphocyte responses in vitro to H-2 d stimulator cells and these treated mice rejected first-set B10.D2 skin grafts within a normal time-course, indicating that at best only a state of partial tolerance had been induced. Spleen cells from these mice failed to develop antibody responses to a variety of antigens in vitro when H-2 d macrophages were in the cultures. Partially purified T cells from these neonatally treated mice suppressed primary antibody responses by normal syngeneic spleen cells in the presence of H-2 d but not other allogeneic macrophages. These radiosensitive, haplotype-specific suppressor T (Ts) cells inhibited primary antibody responses by blocking initiation of the response, but failed to suppress secondary antibody responses and mixed lymphocyte or cytotoxic lymphocyte responses by appropriate responding spleen cells. To activate H-2 d haplotype-specific Ts cells, stimulation with LA d subregion antigen(s) was necessary and sufficient; syngenicity at the I-A subregion of H-2 between the activated Ts cells and target responding spleen cell populations was also necessary and sufficient to achieve suppression. Comparable results have been obtained with spleen cells from BALB/c mice injected as neonates with (B10.D2 × C57BL/10)F1 spleen cells where LA b
